Feature|Articles|September 12, 2023
- Pharmaceutical Executive: September 2023
- Volume 43
- Issue 9
Pharmaceutical Executive, September 2023 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive September 2023 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 2 years ago
A New Era of Ethical Leadershipover 2 years ago
Survival Story: Enhertuover 2 years ago
Gut Instinct: Rebyotaover 2 years ago
Delaying Disease Onset: Tzieldover 2 years ago
New Beginnings: Sunlencaover 2 years ago
A Heartfelt Solution: Camzyosover 2 years ago
Fortifying Defenses Pre-Patent Cliffover 2 years ago
New Product Planning: The Function's Evolution in Pharmaover 2 years ago
No Rate Relief in Sight for BiotechAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
3
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
4
Pharmaceutical Executive Daily: FDA Approves Baxdrostat
5